Downregulation of Plk1 Expression By Receptor-Mediated Uptake of Antisense Oligonucleotide-Loaded Nanoparticles
Human serum albumin (HSA) nanoparticles represent a promising tool for targeted drug delivery to tumor cells. The coupling of the antibody trastuzumab to nanoparticles uses the capability of human epidermal growth factor receptor 2 (HER2)-positive cells to incorporate agents linked to HER2. In our...
Main Authors: | Birgit Spänkuch, Isabel Steinhauser, Heidrun Wartlick, Elisabeth Kurunci-Csacsko, Klaus I Strebhardt, Klaus Langer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-03-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558608801194 |
Similar Items
-
PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
by: Monika Raab, et al.
Published: (2018-03-01) -
Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells
by: Amy E. Arnold, et al.
Published: (2018-06-01) -
Mannosylated Chitosan Nanoparticles for Delivery of Antisense Oligonucleotides for Macrophage Targeting
by: Gyati Shilakari Asthana, et al.
Published: (2014-01-01) -
Antisense oligonucleotides in neurological disorders
by: Claudia D. Wurster, et al.
Published: (2018-05-01) -
The cellular uptake of antisense oligonucleotid of E6 mRNA into cervical cancer cells by DOPE-modified hydroxyapatite nanoparticles
by: Negin Saffarzadeh, et al.
Published: (2014-10-01)